Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

The United Kingdom’s competition regulator started a probe Thursday on the mobile ecosystems of both Alphabet's Google and Apple to gauge whether the tech firms’ ownership of their apps and services ...

Q4 2024 Earnings Call Transcript January 21, 2025 Interactive Brokers Group, Inc. beats earnings expectations. Reported EPS ...